news Award recognises innovative label-free technology 7 February 2020 | By Victoria Rees (Drug Target Review) A Frost & Sullivan award has been given to a new label-free single-cell analysis and sorting platform for utilising cutting-edge technologies.
news Non-therapeutic applications to add revenue to the global human albumin market 6 October 2015 | By Victoria White Frost & Sullivan have found that non-therapeutic use of human albumin as an excipient has generated plenty of interest across the industry...
news Drug abuse triggers regulations to push the development of abuse-free opioid formulations 8 June 2015 | By Victoria White A $10 billion market exists for a company able to develop a novel, targeted opioid therapy that excludes side effects such as addiction and constipation...
news Targeted therapies offer novel treatment modalities for breast cancer 19 March 2015 | By Victoria White While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted therapies is on the rise...
news Oncologic imaging innovation is enabling earlier detection of cancers 4 February 2015 | By Frost & Sullivan Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...